During his time at CME Group, Craig S. Donohue held significant equity in the company, particularly in the restricted stock awarded as part of his compensation package. At the peak of his career, he had nearly 125,000 shares vested upon...

During his time at CME Group, Craig S. Donohue held significant equity in the company, particularly in the restricted stock awarded as part of his compensation package. At the peak of his career, he had nearly 125,000 shares vested upon retirement, valued at over $6.4 million. His holdings reflected both trust in the company's future and a commitment to its performance. Over the years, he exercised various options that further boosted his wealth, particularly exercising 246,000 stock options in 2012 for a realized value of $7.4 million when he stepped down. This wealth was largely tied to the company's success, showcasing how a CEO’s interests can align with shareholders. Despite retiring, his past stakes in CME continue to highlight his impactful role in shaping the organization.